UNH (UNITEDHEALTH GROUP INCORPORATED (Delaware))
Insider Trading Activity
Every open-market purchase and sale reported by UNH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | Patrick Hugh Conway | Chief Executive Officer, Optum | Sell | — | — |
| 2026-08-13 | Dennis Andrew Stankiewicz | Chief Accounting Officer | F | — | — |
| 2026-08-07 | Patrick Hugh Conway | Chief Executive Officer, Optum | Sell | — | — |
| 2026-08-07 | Patrick Hugh Conway | Chief Executive Officer, Optum | Sell | — | — |
| 2026-07-06 | FREDERICK WILLIAM III MCNABB | Director | A | — | — |
| 2026-07-06 | Kristen Gil | Director | A | — | — |
| 2026-07-06 | John H Noseworthy | Director | A | — | — |
| 2026-07-06 | Scott Gottlieb | Director | A | — | — |
| 2026-07-06 | Charles D. Baker | Director | A | — | — |
| 2026-07-06 | RICE VALERIE MD MONTGOMERY | Director | A | — | — |
| 2026-07-06 | PAUL R GARCIA | Director | A | — | — |
| 2026-07-06 | TIMOTHY PATRICK FLYNN | Director | A | — | — |
| 2026-06-25 | Charles D. Baker | Director | A | — | — |
| 2026-06-25 | Scott Gottlieb | Director | A | — | — |
| 2026-06-25 | Timothy John Noel | Chief Executive Officer, UHC | A | — | — |
| 2026-06-25 | Erin McSweeney | EVP & Chief People Officer | A | — | — |
| 2026-06-25 | FREDERICK WILLIAM III MCNABB | Director | A | — | — |
| 2026-06-25 | Christopher R Zaetta | EVP & Chief Legal Officer | A | — | — |
| 2026-06-25 | Wayne S DeVeydt | Chief Financial Officer | A | — | — |
| 2026-06-25 | Kristen Gil | Director | A | — | — |
| 2026-06-25 | RICE VALERIE MD MONTGOMERY | Director | A | — | — |
| 2026-06-25 | PAUL R GARCIA | Director | A | — | — |
| 2026-06-25 | John H Noseworthy | Director | A | — | — |
| 2026-06-25 | Dennis Andrew Stankiewicz | Chief Accounting Officer | A | — | — |
| 2026-06-25 | Patrick Hugh Conway | Chief Executive Officer, Optum | A | — | — |
| 2026-06-25 | TIMOTHY PATRICK FLYNN | Director | A | — | — |
| 2026-06-25 | STEPHEN J HEMSLEY | CEO, UHG | A | — | — |
| 2026-06-09 | Patrick Hugh Conway | Chief Executive Officer, Optum | F | — | — |
| 2026-06-04 | Patrick Hugh Conway | Chief Executive Officer, Optum | F | — | — |
| 2026-06-04 | Christopher R Zaetta | EVP & Chief Legal Officer | F | — | — |
| 2026-04-27 | Patrick Hugh Conway | Chief Executive Officer, Optum | Sell | — | — |
| 2026-04-06 | TIMOTHY PATRICK FLYNN | Director | A | — | — |
| 2026-04-06 | RICE VALERIE MD MONTGOMERY | Director | A | — | — |
| 2026-04-06 | Scott Gottlieb | Director | A | — | — |
| 2026-04-06 | PAUL R GARCIA | Director | A | — | — |
| 2026-04-06 | John H Noseworthy | Director | A | — | — |
| 2026-04-06 | Kristen Gil | Director | A | — | — |
| 2026-04-06 | Charles D. Baker | Director | A | — | — |
| 2026-04-06 | FREDERICK WILLIAM III MCNABB | Director | A | — | — |
| 2026-04-06 | MICHELE J HOOPER | Director | A | — | — |
| 2026-03-19 | Patrick Hugh Conway | Chief Executive Officer, Optum | A | — | — |
| 2026-03-19 | Scott Gottlieb | Director | A | — | — |
| 2026-03-19 | Kristen Gil | Director | A | — | — |
| 2026-03-19 | MICHELE J HOOPER | Director | A | — | — |
| 2026-03-19 | Erin McSweeney | EVP & Chief People Officer | A | — | — |
| 2026-03-19 | Charles D. Baker | Director | A | — | — |
| 2026-03-19 | STEPHEN J HEMSLEY | CEO, UHG | A | — | — |
| 2026-03-19 | TIMOTHY PATRICK FLYNN | Director | A | — | — |
| 2026-03-19 | FREDERICK WILLIAM III MCNABB | Director | A | — | — |
| 2026-03-19 | Timothy John Noel | Chief Executive Officer, UHC | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 8,813,027 | — |
| — | Director | 1,365,487 | — |
| — | CEO, UHG | 1,054,929 | — |
| — | Chief Executive Officer | 968,580 | — |
| — | Director | 929,644 | — |
| — | EVP, UnitedHealth Group | 268,458 | — |
| — | President & CFO | 210,689 | — |
| — | EVP UHG & CEO, Optum | 209,421 | — |
| — | EVP & CEO, UnitedHealthcare | 184,731 | — |
| — | Vice Chmn, UHG and CEO, Optum | 153,789 | — |
| — | EVP & Chief Legal Officer | 147,182 | — |
| — | EVP & Chief Legal Officer | 138,314 | — |
| — | EVP, UnitedHealth Group | 119,908 | — |
| — | EVP & Chief of Medical Affairs | 116,943 | — |
| — | EVP and General Counsel | 113,612 | — |
| — | CEO, UHG | 112,162 | — |
| — | EVP and General Counsel | 101,337 | — |
| — | President & COO, UHG | 94,046 | — |
| — | Director | 85,130 | — |
| — | Director | 74,500 | — |
| — | EVP, Human Capital | 70,660 | — |
| — | Director | 68,425 | — |
| — | EVP & Chief Legal Officer | 63,879 | — |
| — | Director | 62,266 | — |
| — | Director | 59,680 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the UNH quote page; the site-wide leaderboard is on the insider transactions hub.